Cite
HARVARD Citation
von Felden, J. et al. (2018). High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection. Alimentary pharmacology & therapeutics. 47 (9), pp. 1288-1295. [Online].